Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Mercado Continuo Espanol  >  FAES Farma SA    FAE   ES0134950F36

End-of-day quote. End-of-day quote  - 05/30
3.11 EUR   +4.36%
2015 FAES FARMA SA : ex-dividend day for final dividend
2015 FAES FARMA : Statement 05/18/2015 (39 k.). Faes Farma has licensed a..
2015 FAES FARMA : Comunicado 05/01/2015 (59 k.). Dividendo flexible. Dato..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Mercado Continuo Espanol
05/24/2016 05/25/2016 05/26/2016 05/27/2016 05/30/2016 Date
2.85(c) 2.85(c) 2.97(c) 2.98(c) 3.11(c) Last
148 127 201 093 568 206 1 114 065 761 055 Volume
+0.53% 0.00% +4.21% +0.34% +4.36% Change
More quotes
Financials (€)
Sales 2016 221 M
EBIT 2016 43,9 M
Net income 2016 34,0 M
Finance 2016 30,7 M
Yield 2016 1,73%
Sales 2017 236 M
EBIT 2017 60,0 M
Net income 2017 44,0 M
Finance 2017 54,8 M
Yield 2017 2,62%
P/E ratio 2016 21,82
P/E ratio 2017 16,49
EV / Sales 2016 3,45x
EV / Sales 2017 3,13x
Capitalization 793 M
More Financials
Company
Faes Farma SA engages in the manufacture, marketing, and research of pharmaceutical products and raw materials for pharmaceutical use. Its products are for allergies, antihypertensive, dermatological, diabetes, digestive, otorhinolaryngology, osteoarticular, respiratory, women's health, central... 
Sector
Pharmaceuticals
Calendar
07/29Earnings Release
More about the company
Surperformance© ratings of FAES Farma SA
Trading Rating : Investor Rating :
More Ratings
Latest news on FAES FARMA SA
2015 FAES FARMA SA : ex-dividend day for final dividend
2015 FAES FARMA : Statement 05/18/2015 (39 k.). Faes Farma has licensed a pharmaceuti..
2015 FAES FARMA : Comunicado 05/01/2015 (59 k.). Dividendo flexible. Datos de cierre ..
2015 FAES FARMA : Statement 02/27/2015 (81 k.). Faes Farma increases its net probit b..
2014 FAES FARMA : Statement 05/14/2014 (112 k.). Bilastine in Canada: signing of a li..
2014 FAES FARMA : Statement 05/14/2014 (112 k.). Bilastine in Canada: signing of a li..
2013 FAES FARMA SA : Statement 07/24/2013 (24 k.). January-June results.
2012 FAES FARMA SA : Statement 13/12/2012 (20 k). Faes Farma licences bilastine for S..
2012 FAES FARMA SA : Statement 02/07/2012 (19 k). FAES FARMA S.A. informs of the appr..
2012 FAES FARMA SA : ex-dividend day for final dividend
More news
Sector news : Pharmaceuticals - NEC
01:31p BIOGEN : Receives Positive CHMP Opinion for TYSABRI® (Natalizumab) Use in Highly..
01:25p H LUNDBECK A/S : Total number of voting rights and share capital in H. Lundbeck ..
01:02p TEVA PHARMACEUTICAL : Receives Complete Response Letter for NDA for SD-809 for t..
11:46aDJJazz Pharmaceuticals Agrees to Buy Celator for About $1.5 Billion
11:02a CELATOR PHARMACEUTICALS : Jazz Pharma to buy Celator in $1.5 billion deal
More sector news : Pharmaceuticals - NEC
Advertisement
Chart FAES FARMA SA
Duration : Period :
FAES Farma SA Technical Analysis Chart | FAE | ES0134950F36 | 4-Traders
Full-screen chart
Technical analysis trends FAES FARMA SA
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions